BioInvent International AB logo

BioInvent International AB (0H22)

Market Open
7 Aug, 15:30
LSE LSE
kr
22. 82
-0.43
-1.828%
kr
3.21B Market Cap
- P/E Ratio
- Div Yield
1,562 Volume
- Eps
kr 23.25
Previous Close
Add Transaction
Day Range
21.77 23
Year Range
19.46 39.5
Want to track 0H22 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

BioInvent International AB (0H22) Statistics

Valuation metrics

Market Cap 3.21B
Enterprise value 1.16B
Trailing P/E (ttm) -4.52
Forward P/E -
PEG ratio -0.24
Price/Sales (ttm) 6.95
Price/Book (mrq) 3.45
Enterprise Value/Revenue 5.34
Enterprise Value/EBITDA -3.56

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 295
Average volume (90 days) 1.93K

Price summary

52-Week low 19.46
52-Week high 39.5
Beta -
50-Day moving average 23.58
200-Day moving average 24.67

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 14 Dec 2020

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -1.54%
Operating margin -1.61%

Operational effectiveness

Return on assets -0.63%
Return on equity -0.54%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 3.31
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -5.09
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 6.93
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 5.32%
Book value per share (mrq) 6.67

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -